A phase II trial of DuP 937 (Teloxantrone) in non-small cell lung cancer. A study of the NCIC Clinical Trials Group.
| Autor: | Gregg RW; Department of Radiation Oncology, Dalhousie University, Halifax, N.S., Canada., Kaizer L, Fine S, Gelmon K, Wielgosz G, Eisenhauer E |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 1993 Sep; Vol. 4 (8), pp. 693-4. |
| DOI: | 10.1093/oxfordjournals.annonc.a058627 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|